PMC:7795966 / 1210-1452 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"37","span":{"begin":94,"end":98},"obj":"Gene"},{"id":"38","span":{"begin":224,"end":228},"obj":"Gene"},{"id":"53","span":{"begin":34,"end":41},"obj":"Species"},{"id":"54","span":{"begin":50,"end":57},"obj":"Species"},{"id":"56","span":{"begin":60,"end":67},"obj":"Chemical"},{"id":"66","span":{"begin":168,"end":211},"obj":"Disease"}],"attributes":[{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"Gene:2539"},{"id":"A38","pred":"tao:has_database_id","subj":"38","obj":"Gene:2539"},{"id":"A53","pred":"tao:has_database_id","subj":"53","obj":"Tax:9606"},{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"Tax:9606"},{"id":"A56","pred":"tao:has_database_id","subj":"56","obj":"MESH:D005947"},{"id":"A66","pred":"tao:has_database_id","subj":"66","obj":"MESH:D008708"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"nts. The medications given to the patient and the patient’s glucose-6-phospate dehydrogenase (G6PD) status seem to be important factors determining the severity of the methemoglobinemia and carboxyhemoglobinemia. Therefore, G6PD status should"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":168,"end":185},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0012119"}],"text":"nts. The medications given to the patient and the patient’s glucose-6-phospate dehydrogenase (G6PD) status seem to be important factors determining the severity of the methemoglobinemia and carboxyhemoglobinemia. Therefore, G6PD status should"}

{"project":"LitCovid-sentences","denotations":[{"id":"T9","span":{"begin":5,"end":212},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"nts. The medications given to the patient and the patient’s glucose-6-phospate dehydrogenase (G6PD) status seem to be important factors determining the severity of the methemoglobinemia and carboxyhemoglobinemia. Therefore, G6PD status should"}